Riddhi Siddhi Gluco Biols: Promoters Sell Stake to Boost Public Float

Riddhi Siddhi Gluco Biols promoters are set to sell 8.23 lakh shares, representing 11.55% of the company's total equity, through an Offer for Sale (OFS). This action is designed to bring the company into compliance with the Securities and Exchange Board of India's (SEBI) Minimum Public Shareholding (MPS) regulations.

Promoters Launch Offer for Sale

The promoters of Riddhi Siddhi Gluco Biols Ltd. announced plans to divest 8.23 lakh shares via an Offer for Sale (OFS). This constitutes 11.55% of the company's total share capital. The primary objective of this sale is to meet the Minimum Public Shareholding (MPS) norms set by SEBI. This initiative follows directives from SEBI and the Securities Appellate Tribunal (SAT).

Meeting Public Shareholding Requirements

SEBI requires listed companies to maintain at least 25% public shareholding. Promoter holdings, conversely, must not exceed 75%. Companies failing to meet these norms face potential penalties and trading restrictions. This OFS is therefore critical for Riddhi Siddhi Gluco Biols to rectify its previous non-compliance and ensure it adheres to these important corporate governance standards.

Regulatory History and Compliance Efforts

Riddhi Siddhi Gluco Biols, which manufactures starch, liquid glucose, and other corn-based products, has faced regulatory attention regarding its public float. SEBI had previously instructed the company on August 11, 2021, to reduce promoter holding to 75% by June 2017, a deadline the company missed. A recent SAT order on March 9, 2026, has now enabled the promoter's proposed share sale to address this historical non-compliance.

Expected Impact of the Share Sale

• The company is expected to move closer to, or achieve, the mandated 25% public float, improving its compliance status.
• The promoter's direct shareholding percentage will be diluted.
• Successful completion of the sale could boost investor confidence in the company's corporate governance practices.
• A larger number of shares will become available for trading in the market.

Potential Risks and Challenges

• Regulatory Action: If the OFS is not completed within the required timelines, SEBI may initiate further regulatory actions.
• Execution: Market conditions could affect the promoters' ability to sell all intended shares at their target prices, potentially impacting compliance timelines.
• Stock Price: The increased supply of shares from the OFS might lead to downward pressure on the stock price in the short term.

Business Context and Competitors

Riddhi Siddhi Gluco Biols operates in the starch and glucose derivatives market. Competitors include K.P.R. Mill Limited (Agro Division) and India Glycols Limited, a diversified player in chemicals and alcohol. The current share sale is driven by a specific regulatory need rather than a typical strategic move by peers.

Key Shareholding Data

• Current Promoter Shareholding: 75.00% (as of March 2026)
• Current Public Shareholding: 25.00% (as of March 2026)

Investor Watchlist

• Confirmation of the OFS dates and the price band set by the promoter.
• The total volume of shares successfully sold during the OFS.
• Subsequent company disclosures on its updated shareholding pattern.
• The market's reaction to the increased public float and the stock's performance post-OFS.

Reader Takeaway: Promoter stake sale aims for regulatory compliance; market reaction to new shares will be key.